Phase 3 biotech developing immunotherapies for various cancers.
Industry: Health Care
Latest Trade: $2.20 0.00 (0.0%)
First Day Return: -34.8%
Return from IPO: -90.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/27/2023 |
Offer Price | $23.00 |
Price Range $23.00 - $23.00 | |
Offer Shares (mm) | 2.5 |
Deal Size ($mm) | $58 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/29/2023 |
Offer Price | $23.00 |
Price Range $23.00 - $23.00 | |
Offer Shares (mm) | 2.5 |
Deal Size ($mm) | $58 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Cantor Fitzgerald |
Company Data | |
---|---|
Headquarters | Grand Cayman, Cayman Islands |
Founded | 2004 |
Employees at IPO | 129 |
Website www.adlainortye.com |